Intracellular targeted delivery of compounds by 70 kD heat shock protein
AssigneeBristol-Myers Squibb Company
InventorsSheri M. Fujihara, Steven G. Nadler
Life of this patent
Estimating the term…
Abstract
The present invention provides a carrier for the delivery of molecules with biological function into both cellular and nuclear compartments. The carrier disclosed is heat shock protein 70 (“Hsp70”), or a fragment of Hsp70 as described herein, as a vehicle for directed, noninvasive delivery of molecules, such as proteins, peptides, or DNA, that may modulate cellular activity. The present invention also encompasses the use of Hsp70, or a fragment thereof, to modulate cellular activity, preferably to modulate nuclear activity in a cell or cells.
Claims35
A method for delivering a compound into a cell or cells, said method comprising:
- covalently joining said compound with Hsp70, or a fragment of Hsp70 capable of intracellular and intranuclear transport, to form an Hsp70 complex, and
- exogenously providing said Hsp70 complex to said cell or cells so that said Hsp70 complex is imported into said cell or cells,
- wherein said compound is a nuclear protein or nuclear peptide.
A method of delivering a nuclear protein or nuclear peptide to the nuclear compartment of a cell or cells, said method comprising:
- covalently joining said nuclear protein or nuclear peptide with Hsp70, or a fragment of Hsp70 capable of intracellular and intranuclear transport, to form an Hsp70 complex, and
- exogenously providing said complex to said cell or cells so that said complex is transported into the nuclear compartment of said cell or cells.
A pharmaceutical composition comprising an Hsp70 complex, said Hsp70 complex comprising a first portion and a second portion covalently joined,
- said first portion comprising Hsp70 protein, or a fragment thereof capable of intracellular and intranuclear transport;
- and
- said second portion comprising a nuclear protein or nuclear peptide.
A method of delivering a compound into a cell or cells, said method comprising:
- associating said compound with Hsp70, or a fragment of Hsp70 capable of intracellular and intranuclear transport, to form an Hsp70 complex;
- and
- providing said Hsp70 complex to said cell or cells or to the environment surrounding said cell or cells so that said Hsp70 complex is imported into said cell or cells;
- wherein said compound comprises residues 37-409 of the p50 subunit of the transcription factor NF-κB as shown in SEQ ID NO:1.
A pharmaceutical composition comprising an Hsp70 complex, said Hsp70 complex comprising a first portion and a second portion covalently joined,
- said first portion comprising Hsp70 of human origin, or a fragment of Hsp70 of human origin capable of intracellular and intranuclear transport, and
- said second portion comprising a nuclear protein or nuclear peptide.
Dependencies are inferred from the claim text.